Follow
Joakim Ringblom
Joakim Ringblom
Unknown affiliation
Verified email at ki.se
Title
Cited by
Cited by
Year
Current modeling practice may lead to falsely high benchmark dose estimates
J Ringblom, G Johanson, M Öberg
Regulatory Toxicology and Pharmacology 69 (2), 171-177, 2014
192014
Inhibitory effects on osteoblast differentiation in vitro by the polychlorinated biphenyl mixture Aroclor 1254 are mainly associated with the dioxin-like constituents
M Herlin, M Öberg, J Ringblom, B Joseph, M Korkalainen, M Viluksela, ...
Toxicology In Vitro 29 (5), 876-883, 2015
162015
A probabilistic approach to evaluate the risk of decreased total triiodothyronine hormone levels following chronic exposure to PFOS and PFHxS via contaminated drinking water
AV Silva, J Ringblom, C Lindh, K Scott, K Jakobsson, M Öberg
Environmental Health Perspectives 128 (7), 076001, 2020
132020
The point of transition on the dose‐effect curve as a reference point in the evaluation of in vitro toxicity data
S Sand, J Ringblom, H Håkansson, M Öberg
Journal of Applied Toxicology 32 (10), 843-849, 2012
112012
Assigning ethical weights to clinical signs observed during toxicity testing
J Ringblom, E Törnqvist, SO Hansson, C Rudén, M Öberg
ALTEX-Alternatives to animal experimentation 34 (1), 148-156, 2017
82017
Influence of distribution of animals between dose groups on estimated benchmark dose and animal distress for quantal responses
F Kalantari, J Ringblom, S Sand, M Öberg
Risk Analysis 37 (9), 1716-1728, 2017
72017
Influence of distribution of animals between dose groups on estimated benchmark dose and animal welfare for continuous effects
J Ringblom, F Kalantari, G Johanson, M Öberg
Risk Analysis 38 (6), 1143-1153, 2018
52018
Benchmark dose-response analyses for multiple endpoints in drug safety evaluation
AV Silva, J Ringblom, P Moldeus, E Törnqvist, M Öberg
Toxicology and Applied Pharmacology 433, 115732, 2021
32021
Worth Weighting for: Studies on Benchmark Dose Analysis in Relation to Animal Ethics in Toxicity Testing
J Ringblom
PQDT-Global, 2016
32016
Current modeling practice may lead to falsely high benchmark dose estimates
M Öberg, J Ringblom, G Johanson
Toxicology Letters, S123-S124, 2014
22014
Probabilistic risk of decreased levels of triiodothyronine following chronic exposure to PFOS and PFHxS
M Oberg, A Da Silva, J Ringblom, K Scott, C Lindh, K Jakobsson
Toxicol. Lett 295, S224, 2018
12018
P22-19 Benchmark dose-response analyses for multiple endpoints in drug safety evaluation
AV Da Silva, J Ringblom, P Moldeus, E Törnqvist, M Öberg
Toxicology Letters 368, S277-S278, 2022
2022
Erratum:“A Probabilistic Approach to Evaluate the Risk of Decreased Total Triiodothyronine Hormone Levels following Chronic Exposure to PFOS and PFHxS via Contaminated Drinking …
AV Silva, J Ringblom, C Lindh, K Scott, K Jakobsson, M Öberg
Environmental Health Perspectives 128 (8), 089001, 2020
2020
Refined animal toxicity testing using unequally sized dose groups and Benchmark dose analysis
M Öberg, J Ringblom, F Kalantari, G Johanson
Toxicology Letters, S228, 2013
2013
Refined animal toxicity testing using unequally sized dose groups and Benchmark Dose
J Ringblom, G Johanson, M Öberg
Toxicology Letters, S60, 2012
2012
Research Article Assigning ethical weights to clinical signs observed during toxicity testing
J Ringblom, E Törnqvist, SO Hansson, C Rudén, M Öberg
The system can't perform the operation now. Try again later.
Articles 1–16